PULSE BIOSCIENCES, INC. — Director's Dealing 2017

May 18, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2017-05-16

Reporting Person: Dow Brian B (CFO & SVP Admin. and Finance)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-05-16	Stock Option (right to buy)	$27.14	A	95000	Acquired	2027-05-16	Common Stock (95000)	Direct

Footnotes

F1: The shares subject to the option will vest in equal monthly installments over a four year period that began on February 15, 2017, subject to the Reporting Person's continued service through each vesting date.